M&A Deal Summary |
|
|---|---|
| Date | 2021-05-26 |
| Target | Nuventra Pharma Sciences |
| Sector | Life Science |
| Buyer(s) | Allucent |
| Deal Type | Add-on Acquisition |
SEARCH BY
Allucent is a provider of solutions that support life science organizations with advancing drug development. Allucent offers a range of services including regulatory strategy and submissions, project management, medical writing, biostatistics, data management, pharmacokinetics, pharmacovigilance, quality assurance, and trial management. Allucent was founded in 1988 and is based in Cary, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 4 |
| Sector: Life Science M&A | 3 of 4 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: North Carolina M&A | 3 of 3 |
| Country: United States M&A | 2 of 2 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-15 |
Array Biostatistics
Wilmington, North Carolina, United States Array Biostatistics LLC is a full-service biostatistical and statistical programming CRO for the biopharmaceutical industry. Array provides individualized, adaptable, and dedicated services to all of our customers with a team of highly experienced biostatisticians and statistical programmers. Array Biostatistics was established in 2012 and is based in Wilmington, North Carolina. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-05 |
Pharm-Olam International
Bracknell, United Kingdom Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines, making clinical research as Easy As I, II, III, IV™. |
Buy | - |
